Delta Financial Group, Inc.
- SEC CIK
- 0001965718
- Latest filing
- May 9, 2025
SEEL holding history
Seelos Therapeutics, Inc. in every 13F filed by Delta Financial Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SEEL overviewAll 13F holders of SEELFull Q1 2025 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −667−100.0% | Sold outConverted for a 1-for-30 split | Holders |
| Q3 2023 | 20,000 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 20,000 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 20,000 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 20,000 | $14.0K | <0.1% | – | No prior filing | Holders |